Recent progress in atherosclerosis research; experimental and clinical aspects.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D001792:Blood Platelets / Q000187:drug effects; D002455:Cell Division; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D004727:Endothelium / Q000473:pathology; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D013927:Thrombosis / Q000097:blood / Q000209:etiology
D000925:Anticoagulants; D008074:Lipoproteins; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D002994:Clofibrate; D009355:Neomycin